SKP.L Regulatory News (SKP)

11 Dec 2007 11:31

Skyepharma PLC11 December 2007 TR-1: notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing SKYEPHARMA PLCshares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box or boxes)An acquisition or disposal of voting rights XAn acquisition or disposal of financial instruments which may result in the acquisition ofshares already issued to which voting rights are attachedAn event changing the breakdown of voting rightsOther (please specify):___________________________________________ 3. Full name of person(s) subject to the notification The Goldman Sachs Group, Inc.obligation: 4. Full name of shareholder(s) (if different from 3.): Goldman, Sachs & Co. Goldman Sachs International5. Date of the transaction (and date on which the threshold is 06 DECEMBER 2007crossed or reached if different): 6. Date on which issuer notified: 10 DECEMBER 2007 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified details: A: Voting rights attached to sharesClass/type of Situation previous to Resulting situation after the triggering transactionshares the Triggering transaction if possible Number of Number of Number of Number of voting rights % of voting rightsusing the ISIN Shares Voting shares ixCODE Rights viii Direct Direct x Indirect xi Direct Indirect GB0008123571 33,569,609 4.11% 214,737 41,022,149 0.03% 5.03% B: Financial InstrumentsResulting situation after the triggering transaction xiiType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument xiii Period/ Date xiv that may be acquired if rights the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 41,236,886 5.06% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable xv:The interest in 14 shares arose from a beneficial interest held by Goldman, Sachs & Co. ("GS&Co."), a direct subsidiaryof GS Inc. These shares are, or will be, registered in the name of Goldman Sachs Securities (Nominees), Limited ("GSSN"). The interest in 41,022,149 shares arose from an interest held by Goldman, Sachs & Co., a wholly-owned direct subsidiaryof GS Inc, acting as custodian for its customers. These shares are, or will be, registered in the name of Goldman SachsSecurities (Nominees), Limited. The interest in 214,723 shares arose from a beneficial interest held by Goldman Sachs International, a wholly-ownedindirect subsidiary of GS Inc. These shares are, or will be, registered at CREST in account CREPTEMP. Proxy Voting:10. Name of the proxy holder: N/A11. Number of voting rights proxy holder will cease to hold: N/A12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: General email contact: shareholderdisclosures@gs.com 14. Contact name: Sean Rogers / Alan Cox 15. Contact telephone number: 0207-552-9205 / 0207-774 -8774 This information is provided by RNS The company news service from the London Stock Exchange